Health

New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

Managing Editor · Saturday, October 24, 2026 at 11:30 AM · 1 min read

New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent — Wired, Bangalore Health news — Image: Wired

The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.

Up nextGerman traveller reveals 10 things she wishes she knew before travelling to India as a solo travellerHealth · 1 min read

More Health stories

Health

German traveller reveals 10 things she wishes she knew before travelling to India as a solo traveller

By Katherine Langford

Mint India

Technology

Best Pet Camera of 2026: Furbo, Petcube, and Enabot

By Marcus Chen

Wired

Technology

9 Unique Apps to Try on the iPhone Duo

By Marcus Chen

Wired

Technology

My Favorite Sofa Is Discounted for Joybird’s Semiannual Sale

By Katherine Langford

Wired

New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

Text size

Typeface

Line spacing

Theme

Focus mode

More Health stories

German traveller reveals 10 things she wishes she knew before travelling to India as a solo traveller

Best Pet Camera of 2026: Furbo, Petcube, and Enabot

9 Unique Apps to Try on the iPhone Duo

My Favorite Sofa Is Discounted for Joybird’s Semiannual Sale